Tuesday July 7, 2020 03:32

Food and Healthcare Press Releases

Affinity discovers potent SARS-CoV-2 antibodies Heathcare—02 Jul 20

Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for cancer therapeutics, today announces the discovery of potent antibodies with therapeutic potential against COVID-19. In March, Affinity

Traditional Chinese medicine tourism and health care base rising in north China's Taihang Mountains Heathcare—02 Jul 20

Deep in the Taihang Mountains in north China, a group of workers are busy planting local authentic traditional Chinese medicines (TCM) in the Bian Que TCM Valley, the largest TCM planting base in Neiqiu County, Xingtai City, Hebei Province. The valley is

CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Heathcare—02 Jul 20

CF PharmTech, Inc. ("CF PharmTech") announced today that it has raised US $50M in Series F financing following its US $90M Series E financing in January of 2020, in total, successfully completing an equity investment deal of nearly US $140M within six

Zhejiang Hisun Pharmaceutical: COVID-19 Pandemic Brought Under Control in China With Favipiravir Heathcare—01 Jul 20

COVID-19 has become a global pandemic. China's successful control of the pandemic has set a good example for other countries. Many have followed China to take effective measures like enforcing lockdowns and wearing masks have all been proved to be

Almost Half of Children Are Not Always Using Soap When Washing Hands at School, New Survey by the Heathcare—01 Jul 20

Leading hygiene experts are stressing the importance of effective hand hygiene measures and education in schools as children begin returning to educational settings following the COVID-19 pandemic The calls follow a new global survey conducted by The

RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for Heathcare—30 Jun 20

RevImmune, a privately held biotechnology company developing CYT107 immune therapy for infectious diseases and cancer, announced today that it has launched the "ILIAD" Phase II trial for treatment of COVID-19. Many COVID-19 clinical trials have focused

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Heathcare—30 Jun 20

MedAlliance has announced the award of its second CE Mark: SELUTION SLR(TM) 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as in-stent

GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical Heathcare—29 Jun 20

Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SBC-2019 GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered

Medicom Announces UK Mask Manufacturing Facility in Alliance with British Heathcare—26 Jun 20

The Medicom Group, ("Medicom"), one of the world's leading manufacturers of medical and respiratory masks, has announced the further expansion of its global footprint with the plan to open a new mask manufacturing facility in the United Kingdom this

B. Braun (Thailand) and Thai ET nurses enter a signing of MOA to enhance efficiency of Thai Heathcare—25 Jun 20

B. Braun (Thailand) Ltd., supplier and distributor of medical, pharmaceutical products and services in Thailand represented by Mr. Sayan Roy, Managing Director, along with the management team signed a Memorandum of Agreement (MOA) for “Poster

ERBA Mannheim Launches CE Marked COVID-19 IgM Antibody ELISA Heathcare—25 Jun 20

In response to the ongoing COVID-19 pandemic, Erba Mannheim today launched the ErbaLisa COVID-19 IgM ELISA kit for detection of IgM antibodies to SARS-CoV-2. IgM antibodies are produced first and detectable during disease onset, so using the new assay

deCODE Genetics: Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Heathcare—25 Jun 20

- The combination of genomics, transcriptomics and proteomics sheds light on autoimmune thyroid disease, other autoimmune diseases and AML Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare

Global Fund COVID-19 Report: Deaths from HIV, TB and Malaria Could Almost Double in 12 Months Heathcare—24 Jun 20

A new report released by the Global Fund today estimates that countries affected by HIV, tuberculosis and malaria urgently need US$28.5 billion to protect the extraordinary progress achieved in the fight against the three diseases in the past two

IgNova Files Patent Application on Antibody Against COVID-19 Heathcare—24 Jun 20

IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins

Docquity Works with the Indonesian Ministry of Health in Recruiting over 800 Doctors across Heathcare—22 Jun 20

The need for medical personnel at hospitals all across Indonesia increased rapidly ever since COVID-19 hit Indonesia in March. Docquity -- S.E Asia's largest professional network of doctors, stepped up to this challenge and in partnership with the

Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Heathcare—18 Jun 20

Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the company is in talks

NCCN เผยแพร่คู่มือดูแลรักษาผู้ป่วยโรคมะเร็งในเด็กฉบับแปลหลายภาษา Heathcare—17 Jun 20

สามารถอ่านคู่มือ NCCN Guidelines for Pediatric Acute Lymphoblastic Leukemia ฉบับภาษาจีน ญี่ปุ่น ฝรั่งเศส สเปน และโปรตุเกส ได้ฟรีที่ NCCN.org National Comprehensive Cancer Network(R) (NCCN(R))

NCCN Works to Improve Global Cancer Care for Children with Newly Translated Heathcare—17 Jun 20

NCCN Guidelines for Pediatric Acute Lymphoblastic Leukemia in Chinese, Japanese, French, Spanish, and Portuguese are now available for free at NCCN.org The National Comprehensive Cancer Network(R) (NCCN(R))—an alliance of leading cancer centers in

DERMALOG Contactless Fever Checks at Medical Practices Heathcare—17 Jun 20

- Due to the corona pandemic, general practitioners and specialists face the challenge of maintaining their practice without putting patients and staff at increased risk of infection. In Hamburg, Germany, another medical practice has implemented health

Investigational, Once-weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-daily Heathcare—15 Jun 20

Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analogue. In the trial, adults with type 2 diabetes randomised to once-weekly insulin icodec achieved similar blood sugar

Switching to Ozempic(R) from another GLP-1 RA significantly reduced blood sugar and weight in Heathcare—15 Jun 20

- A separate real-world study showed that people with type 2 diabetes on two oral antidiabetic drugs who intensified with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) were significantly more likely to reach their blood sugar goals and lose

Ortho's VITROS(R) B.R.A.H.M.S PCT Assay for Sepsis Now Available Heathcare—12 Jun 20

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS(R) B.R.A.H.M.S PCT (Procalcitonin) assay, now commercially available to

DERMALOG Fever Check at Greifswald University Hospital Heathcare—12 Jun 20

- Due to the corona pandemic, hospitals and clinics face the challenge of maintaining practice without putting patients and staff at increased risk of infection. Greifswald University Hospital in Germany has implemented health protection measures using

Menarini Group Completes a Solid Year of Operating Performance Heathcare—11 Jun 20

- Turnover reaches EUR3,793 million, with an increase of 3.2% compared to 2018 and EBITDA of EUR492 million thanks to continued strong performance of its most important products - EUR150 million investment into new plant in Italy significantly